Researchers plan to apply technology to other diseases

After three years and 300 patients, researchers have proof that their early-detection urine test for Lyme disease works. In the case of Lyme disease, some patients may still have active cases but traditional tests don't register it, and these patients may not be receiving the additional round of treatment they need, authors say. And now Mason researchers are applying the approach to Ebola, malaria and tuberculosis, among other diseases. The Mason team is working side by side with the private company Ceres Nanoscience, which Liotta and his co-director Chip Petricoin co-founded. A test that works like a pregnancy test could be used in undeveloped countries to quickly identify disease, even when patients aren't near a hospital.

Source :      2016/5/24 10:07

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.